Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13875372 | 1.00 | CYP2D6 (0.49) | CYP2D6ALDH1A1MAPK1TSHRLMNA | |
| SCHEMBL13875392 | 0.90 | CYP2D6 (0.48) | CYP2D6ALDH1A1MAPK1TSHRLMNA | |
| SCHEMBL8977510 | 0.84 | TSHR (0.61) | CYP2D6ALDH1A1MAPK1TSHRLMNA | |
| SCHEMBL14257938 | 0.83 | PTPN1 (0.52) | CYP2D6ALDH1A1MAPK1TSHRLMNA | |
| SCHEMBL14257941 | 0.83 | PTPN1 (0.52) | CYP2D6ALDH1A1MAPK1TSHRLMNA | |
| SCHEMBL13890470 | 0.83 | CYP2D6 (0.44) | CYP2D6MAPK1TSHRLMNAKMT2A | |
| SCHEMBL23742930 | 0.81 | TSHR (0.64) | CYP2D6ALDH1A1MAPK1TSHRLMNA | |
| SCHEMBL15514610 | 0.81 | TSHR (0.64) | CYP2D6ALDH1A1MAPK1TSHRLMNA | |
| SCHEMBL10359936 | 0.81 | TSHR (0.64) | CYP2D6ALDH1A1MAPK1TSHRLMNA | |
| SCHEMBL8722654 | 0.81 | TSHR (0.64) | CYP2D6ALDH1A1MAPK1TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8513395-B2 | Method for the synthesis of anthocyanins | BIOSYNTH AS (NO) | 2013-08-20 | — | — | US | disclosed |
| EP-1891086-B1 | METHOD FOR THE SYNTHESIS OF ANTHOCYANINS | BIOSYNTH AS (NO) | 2011-08-24 | — | — | EP | disclosed |
| US-20090111975-A1 | METHOD FOR THE SYNTHESIS OF ANTHOCYANINS | BIOSYNTH AS (NO) | 2009-04-30 | — | — | US | disclosed |
| EP-1891086-A1 | METHOD FOR THE SYNTHESIS OF ANTHOCYANINS | Biosynth AS (NO) | 2008-02-27 | — | — | EP | disclosed |
| WO-2006134352-A1 | METHOD FOR THE SYNTHESIS OF ANTHOCYANINS | BIOSYNTH AS (NO) | 2006-12-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090111975-A1 | METHOD FOR THE SYNTHESIS OF ANTHOCYANINS | POR, SPR, G6PD | CYP2D6 195/4885ALDH1A1 967/4885MAPK1 741/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.